Literature DB >> 12920846

In vitro and in vivo characterization of a dual-function green fluorescent protein--HSV1-thymidine kinase reporter gene driven by the human elongation factor 1 alpha promoter.

Gary D Luker1, Kathryn E Luker, Vijay Sharma, Christina M Pica, Julie L Dahlheimer, Joe A Ocheskey, Timothy J Fahrner, Jeffrey Milbrandt, David Piwnica-Worms.   

Abstract

Toward the goal of monitoring activity of native mammalian promoters with molecular imaging techniques, we stably transfected DU145 prostate carcinoma cells with a fusion construct of enhanced green fluorescent protein (EGFP) and wild-type herpes simplex virus-1 thymidine kinase (HSV1-TK) as a reporter gene driven by the promoter for human elongation factor 1 alpha (EF-1 alpha-EGFP-TK). Using this model system, expression of EGFP was quantified by flow cytometry and fluorescence microscopy, while the HSV1-TK component of the reporter was quantified with 8-[3H]ganciclovir (8-[3H]GCV). As analyzed by flow cytometry, passage of EGFP-TK-DU145 transfected cells (ETK) in vitro resulted in populations of cells with high and low expression of EGFP over time. High and low ETK cells retained 23-fold and 5-fold more GCV, respectively, than control. While differences in uptake and retention of GCV corresponded to relative expression of the reporter gene in each subpopulation of cells as determined by both flow cytometry (EGFP) and quantitative RT-PCR, the correlation was not linear. Furthermore, in high ETK cells, net retention of various radiolabeled nucleoside analogues varied; the rank order was 8-[3H]GCV < 9-(4-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) approximately 8-[3H]penciclovir (8-[3H]PCV) < 2'-fluoro-2'-deoxy-5-iodouracil-beta-D-arabinofuranoside (2-[14C]FIAU). Xenograft tumors of ETK cells in vivo accumulated 2.5-fold more 8-[3H]GCV per gram of tissue and showed greater fluorescence from EGFP than control DU145 cells, demonstrating that the reporter gene functioned in vivo. These data extend previous reports by showing that a human promoter can be detected in vitro and in vivo with a dual-function reporter exploiting optical and radiotracer techniques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12920846     DOI: 10.1162/153535002320162714

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   4.488


  6 in total

1.  Noninvasive imaging of protein-protein interactions in living animals.

Authors:  Gary D Luker; Vijay Sharma; Christina M Pica; Julie L Dahlheimer; Wei Li; Joseph Ochesky; Christine E Ryan; Helen Piwnica-Worms; David Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 2.  Molecular imaging of pulmonary disease in vivo.

Authors:  Robin S Dothager; David Piwnica-Worms
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

3.  HaloTag: a novel reporter gene for positron emission tomography.

Authors:  Hao Hong; Hélène A Benink; Yin Zhang; Yunan Yang; H Tetsuo Uyeda; Jonathan W Engle; Gregory W Severin; Mark G McDougall; Todd E Barnhart; Dieter H Klaubert; Robert J Nickles; Frank Fan; Weibo Cai
Journal:  Am J Transl Res       Date:  2011-07-28       Impact factor: 4.060

4.  Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.

Authors:  Khun Visith Keu; Timothy H Witney; Shahriar Yaghoubi; Jarrett Rosenberg; Anita Kurien; Rachel Magnusson; John Williams; Frezghi Habte; Jamie R Wagner; Stephen Forman; Christine Brown; Martin Allen-Auerbach; Johannes Czernin; Winson Tang; Michael C Jensen; Behnam Badie; Sanjiv S Gambhir
Journal:  Sci Transl Med       Date:  2017-01-18       Impact factor: 17.956

5.  Imaging gene expression in live cells and tissues.

Authors:  Hao Hong; Yunan Yang; Weibo Cai
Journal:  Cold Spring Harb Protoc       Date:  2011-04-01

6.  Human breast tumor cells express multimodal imaging reporter genes.

Authors:  Kurt M Lin; Ching-Han Hsu; Wun-Shaing W Chang; Chiung-Tong Chen; Te-Wei Lee; Chin-Tu Chen
Journal:  Mol Imaging Biol       Date:  2008-06-17       Impact factor: 3.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.